FOMX | | Foamix Pharmaceuticals Ltd. | Wiley Matthew T. | Chief Commercial Officer | Mar 02, 2020 | Option Exercise | $2.68 | 1,993 | 5,336 | 114,074 | Mar 03, 2020, 12:00 AM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Mar 02, 2020 | Option Exercise | $2.68 | 4,705 | 12,598 | 324,028 | Mar 03, 2020, 12:00 AM |
FOMX | | Foamix Pharmaceuticals Ltd. | Harsch Mutya | CLO and General Counsel | Mar 02, 2020 | Option Exercise | $2.68 | 1,761 | 4,715 | 98,232 | Mar 03, 2020, 12:00 AM |
FOMX | | Foamix Pharmaceuticals Ltd. | Wiley Matthew T. | Chief Commercial Officer | Dec 31, 2019 | Option Exercise | $3.28 | 2,500 | 8,200 | 70,782 | Jan 03, 2020, 05:24 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Stuart Iain | Chief Scientific Officer | Dec 31, 2019 | Option Exercise | $3.28 | 514 | 1,686 | 62,337 | Jan 03, 2020, 05:23 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Harsch Mutya | CLO and General Counsel | Dec 31, 2019 | Option Exercise | $3.28 | 618 | 2,027 | 55,172 | Jan 03, 2020, 05:23 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Dec 31, 2019 | Option Exercise | $3.28 | 2,751 | 9,023 | 216,075 | Jan 03, 2020, 05:22 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Nov 29, 2019 | Option Exercise | $2.16 | 9,842 | 21,249 | 218,826 | Dec 03, 2019, 04:32 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Wiley Matthew T. | Chief Commercial Officer | Nov 29, 2019 | Option Exercise | $2.16 | 9,842 | 21,249 | 73,282 | Dec 03, 2019, 04:31 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Harsch Mutya | CLO and General Counsel | Nov 29, 2019 | Option Exercise | $2.16 | 4,284 | 9,249 | 55,790 | Dec 03, 2019, 04:30 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Hirsch Stanley | Director | Nov 04, 2019 | Option Exercise | $0.62 | 32,500 | 20,150 | 182,500 | Nov 05, 2019, 04:32 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Hirsch Stanley | Director | Oct 15, 2019 | Option Exercise | $0.62 | 90,000 | 55,800 | 150,000 | Oct 17, 2019, 04:11 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Stuart Iain | Chief Scientific Officer | Sep 30, 2019 | Option Exercise | $3.07 | 673 | 2,066 | 62,851 | Oct 02, 2019, 04:20 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Harsch Mutya | CLO and General Counsel | Sep 30, 2019 | Option Exercise | $3.07 | 463 | 1,421 | 51,506 | Oct 02, 2019, 04:19 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Sep 30, 2019 | Option Exercise | $3.07 | 2,256 | 6,926 | 208,984 | Oct 02, 2019, 04:18 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Hadar Ilan | CFO & Country Manager | Sep 09, 2019 | Sale | $3.50 | 9,420 | 32,991 | 123,671 | Sep 11, 2019, 05:12 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Hadar Ilan | CFO & Country Manager | Sep 10, 2019 | Sale | $3.50 | 34,392 | 120,375 | 89,279 | Sep 11, 2019, 05:12 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | KAZANCHYAN ANNA | Director | Aug 26, 2019 | Sale | $3.27 | 7,049 | 23,050 | 37,498 | Aug 28, 2019, 04:36 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Hirsch Stanley | Director | Aug 13, 2019 | Option Exercise | $0.62 | 60,000 | 37,200 | 60,000 | Aug 14, 2019, 02:59 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | KAZANCHYAN ANNA | Director | Jul 15, 2019 | Sale | $2.31 | 808 | 1,866 | 44,547 | Jul 17, 2019, 04:40 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Harsch Mutya | CLO and General Counsel | Jul 01, 2019 | Sale | $2.35 | 639 | 1,502 | 51,969 | Jul 03, 2019, 04:28 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Jul 01, 2019 | Sale | $2.35 | 3,355 | 7,884 | 211,240 | Jul 03, 2019, 04:27 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Stuart Iain | Chief Scientific Officer | Jul 01, 2019 | Sale | $2.35 | 951 | 2,235 | 63,524 | Jul 03, 2019, 04:26 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | KAZANCHYAN ANNA | Director | May 20, 2019 | Sale | $2.61 | 10,600 | 27,666 | 45,355 | May 20, 2019, 06:35 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Harsch Mutya | CLO and General Counsel | Apr 01, 2019 | Sale | $3.75 | 2,519 | 9,446 | 52,608 | Apr 03, 2019, 04:42 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Apr 01, 2019 | Sale | $3.75 | 5,096 | 19,110 | 214,595 | Apr 03, 2019, 04:40 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Stuart Iain | Chief Scientific Officer | Apr 01, 2019 | Sale | $3.75 | 1,696 | 6,360 | 64,475 | Apr 03, 2019, 12:00 AM |
FOMX | | Foamix Pharmaceuticals Ltd. | Wiley Matthew T. | Chief Commercial Officer | Mar 05, 2019 | Buy | $3.76 | 13,440 | 50,534 | 63,440 | Mar 06, 2019, 04:07 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Schwartz Aharon | Director | Nov 28, 2018 | Buy | $3.88 | 12,200 | 47,373 | 112,200 | Dec 06, 2018, 06:09 AM |
FOMX | | Foamix Pharmaceuticals Ltd. | Schwartz Aharon | Director | Nov 26, 2018 | Buy | $3.89 | 50,000 | 194,600 | 50,000 | Dec 06, 2018, 06:09 AM |
FOMX | | Foamix Pharmaceuticals Ltd. | Schwartz Aharon | Director | Nov 27, 2018 | Buy | $3.92 | 50,000 | 195,800 | 100,000 | Dec 06, 2018, 06:09 AM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Dec 03, 2018 | Sale | $4.05 | 68 | 275 | 146,409 | Dec 06, 2018, 06:06 AM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Nov 19, 2018 | Sale | $3.90 | 5,036 | 19,640 | 146,477 | Nov 20, 2018, 04:07 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Howard Alvin D | VP Regulatory | Nov 19, 2018 | Sale | $3.90 | 3,375 | 13,163 | 38,414 | Nov 20, 2018, 04:05 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Stuart Iain | SVP R&D | Nov 08, 2018 | Sale | $4.58 | 683 | 3,128 | 33,602 | Nov 13, 2018, 06:16 AM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Nov 08, 2018 | Sale | $4.58 | 2,062 | 9,444 | 151,513 | Nov 13, 2018, 06:13 AM |
FOMX | | Foamix Pharmaceuticals Ltd. | Howard Alvin D | VP Regulatory | Oct 01, 2018 | Sale | $5.81 | 234 | 1,360 | 41,789 | Oct 02, 2018, 05:22 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Elliott Russell P. | VP Drug Development | Oct 01, 2018 | Sale | $5.81 | 142 | 825 | 12,442 | Oct 02, 2018, 05:20 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Oct 01, 2018 | Sale | $5.81 | 601 | 3,492 | 153,575 | Oct 02, 2018, 05:18 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Sep 04, 2018 | Sale | $5.67 | 67 | 380 | 154,176 | Sep 06, 2018, 04:05 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Aug 08, 2018 | Sale | $5.68 | 8,238 | 46,792 | 154,243 | Aug 09, 2018, 04:07 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Stuart Iain | SVP R&D | Aug 08, 2018 | Sale | $5.68 | 2,715 | 15,421 | 34,285 | Aug 09, 2018, 04:05 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Jul 02, 2018 | Sale | $5.10 | 602 | 3,070 | 162,481 | Jul 03, 2018, 04:09 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Howard Alvin D | VP Regulatory | Jul 02, 2018 | Sale | $5.10 | 234 | 1,193 | 42,023 | Jul 03, 2018, 04:07 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Elliott Russell P. | VP Drug Development | Jul 02, 2018 | Sale | $5.10 | 142 | 724 | 12,584 | Jul 03, 2018, 04:05 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Jun 01, 2018 | Sale | $5.26 | 67 | 352 | 163,083 | Jun 04, 2018, 02:20 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Hirsch Stanley | Director | May 13, 2018 | Option Exercise | $5.06 | 12,388 | 62,738 | 12,672 | May 31, 2018, 04:51 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Howard Alvin D | VP Regulatory | Apr 02, 2018 | Sale | $5.08 | 234 | 1,189 | 42,257 | Apr 04, 2018, 12:32 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Elliott Russell P. | VP Drug Development | Apr 02, 2018 | Sale | $5.08 | 142 | 721 | 12,726 | Apr 04, 2018, 12:30 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Apr 02, 2018 | Sale | $5.08 | 602 | 3,058 | 139,754 | Apr 04, 2018, 12:28 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Elliott Russell P. | VP Drug Development | Mar 02, 2018 | Sale | $6.14 | 817 | 5,016 | 12,868 | Mar 06, 2018, 11:50 AM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Mar 01, 2018 | Sale | $5.95 | 66 | 393 | 140,356 | Mar 05, 2018, 11:37 AM |
FOMX | | Foamix Pharmaceuticals Ltd. | Elliott Russell P. | VP Drug Development | Jan 02, 2018 | Option Exercise | $5.98 | 555 | 3,319 | 4,935 | Jan 24, 2018, 08:26 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Domzalski David | CEO | Jan 02, 2018 | Option Exercise | $5.98 | 2,397 | 14,334 | 140,422 | Jan 24, 2018, 08:24 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Howard Alvin D | VP Regulatory | Jan 02, 2018 | Option Exercise | $5.98 | 924 | 5,526 | 34,991 | Jan 24, 2018, 08:22 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Eini Meir | Observer to the Board | Jan 11, 2018 | Sale | $6.33 | 5,000 | 31,658 | 2,717,781 | Jan 18, 2018, 05:10 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Eini Meir | Observer to the Board | Jan 04, 2018 | Sale | $6.68 | 5,000 | 33,411 | 2,742,781 | Jan 18, 2018, 05:10 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Eini Meir | Observer to the Board | Jan 05, 2018 | Sale | $6.58 | 5,000 | 32,882 | 2,737,781 | Jan 18, 2018, 05:10 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Eini Meir | Observer to the Board | Jan 08, 2018 | Sale | $6.17 | 5,000 | 30,850 | 2,732,781 | Jan 18, 2018, 05:10 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Eini Meir | Observer to the Board | Jan 09, 2018 | Sale | $6.10 | 5,000 | 30,520 | 2,727,781 | Jan 18, 2018, 05:10 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Eini Meir | Observer to the Board | Jan 02, 2018 | Sale | $6.18 | 5,000 | 30,903 | 2,752,781 | Jan 18, 2018, 05:10 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Eini Meir | Observer to the Board | Jan 10, 2018 | Sale | $6.05 | 5,000 | 30,227 | 2,722,781 | Jan 18, 2018, 05:10 PM |
FOMX | | Foamix Pharmaceuticals Ltd. | Eini Meir | Observer to the Board | Jan 03, 2018 | Sale | $6.26 | 5,000 | 31,311 | 2,747,781 | Jan 18, 2018, 05:10 PM |